Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism

NICE guideline
Reference number: NG89
Published: 21 March 2018
Last updated: 13 August 2019

History

Surveillance consultation

Surveillance consultation
Consultation questions (PDF 311 KB)

Published:

17 November 2022
Surveillance review proposal (online version)
Surveillance review proposal (PDF version) (PDF 286 KB)

Published:

17 November 2022
Equality impact assessment (PDF 165 KB)

Published:

17 November 2022

Stakeholder list updated

Stakeholder list (PDF 46 KB)

Published:

16 November 2022

Guidance published

Equality impact assessment (PDF 220 KB)

Published:

21 March 2018
Consultation comments and responses (PDF 3.98 MB)

Published:

21 March 2018
Committee member list (PDF 424 KB)

Published:

21 March 2018

Draft guidance consultation

Draft guidance consultation
Draft guideline Vol 1 (PDF 6.68 MB)

Published:

04 December 2017
Draft guideline Vol 2 (PDF 11.1 MB)

Published:

04 December 2017
Short version of draft guideline (PDF 711 KB)

Published:

04 December 2017
Addendum appendicies (PDF 18.12 MB)

Published:

04 December 2017
Addendum appendicies (PDF 21.09 MB)

Published:

04 December 2017
Equality impact assessment (PDF 228 KB)

Published:

04 December 2017
Comments form (MSWord 63 KB)

Published:

04 December 2017

Stakeholder list updated

Stakeholder list (PDF 45 KB)

Published:

03 October 2017

Committee list updated

Committee member list (PDF 168 KB)

Published:

27 October 2016

Committee meetings

Committee meeting
Minutes 1 (PDF 161 KB)

Published:

25 April 2018
Minutes 2 (PDF 162 KB)

Published:

25 April 2018
Minutes 3 (PDF 161 KB)

Published:

25 April 2018
Minutes 4 (PDF 170 KB)

Published:

25 April 2018
Minutes 5 (PDF 170 KB)

Published:

25 April 2018
Minutes 6 (PDF 282 KB)

Published:

25 April 2018
Minutes 7 (PDF 71 KB)

Published:

25 April 2018
Minutes 8 (PDF 281 KB)

Published:

25 April 2018
Minutes 9 (PDF 284 KB)

Published:

25 April 2018
Minutes 10 (PDF 282 KB)

Published:

25 April 2018
Minutes 11 (PDF 73 KB)

Published:

25 April 2018
Minutes 12 (PDF 416 KB)

Published:

25 April 2018
Minutes 13 (PDF 252 KB)

Published:

25 April 2018
Minutes 14 (PDF 412 KB)

Published:

25 April 2018
Minutes 15 (PDF 418 KB)

Published:

25 April 2018
Minutes orthopaedic subgroup 1 (PDF 89 KB)

Published:

25 April 2018
Minutes orthopaedic subgroup 2 (PDF 38 KB)

Published:

25 April 2018
Minutes orthopaedic subgroup 3 (PDF 38 KB)

Published:

25 April 2018
Minutes orthopaedic subgroup 4 (PDF 27 KB)

Published:

25 April 2018
Minutes GC 16 (PDF 555 KB)

Published:

12 April 2019
Minutes GC 17 (PDF 555 KB)

Published:

12 April 2019

Scope published

Final scope Updated April 2016 (PDF 280 KB)

Published:

11 April 2016

Equality and health inequalities assessment

Equality impact assessment (PDF 295 KB)

Published:

14 March 2016

Scope published

Consultation comments and responses (PDF 562 KB)

Published:

26 February 2016
Final scope (PDF 280 KB)

Published:

26 February 2016

Pre-consultation documents released

Search strategies (PDF 524 KB)

Published:

24 August 2017
Review questions (PDF 225 KB)

Published:

24 August 2017
Economic plan (PDF 143 KB)

Published:

24 August 2017

Draft scope consultation

Draft scope consultation
Draft scope (PDF 206 KB)

Published:

11 December 2015
Equality impact assessment (PDF 118 KB)

Published:

11 December 2015
Comments form (MSWord 33 KB)

Published:

11 December 2015

Scoping workshop

Workshop notes (PDF 321 KB)

Published:

11 December 2015